This market research report presents a comprehensive segmentation of the fertility market in the US by treatment type (infertility drugs and ART). It also outlines the market shares for key regions such as the Americas, APAC, and EMEA. The leading vendors in the market are Cellcura, CooperSurgical, Intramed, Ferring Pharmaceuticals, and Merck.
Technavio’s market research analysts estimate the fertility market in the US, to grow at a CAGR of 4% between 2016 and 2020. The fertility market in the US consists of fertility drugs and assisted reproductive technology (ART) services segments. Increasing fertility issues among the aging population, rising disposable income, growing adoption of fertility services by homosexual couples, and augmented support from the US federal government are boosting the growth of fertility market in the US.
The new market research report from Technavio provides a breakdown and analysis of the fertility services segments by technology.
“Vendors are carrying out various research studies and developing latest technologies to enhance better fertility services. Various areas are under research which include genetic mutations that cause infertility, understanding the effects of gynaecologic disorders, developing novel therapeutics for treating infertility, improving detection methods of abnormalities in preimplantation embryos and comprehending the long-term effects of assisted reproductive technology (ART) interventions on parental and child health,” says Brahadeesh Chandrasekaran, Lead Analyst, Healthcare & Lifesciences, Technavio Research.
Currently, the ART segment leads the market and accounts for approximately 67% of the total market share. This segment includes in-vitro fertilization and other treatment options like intrauterine insemination (IUI), reproductive surgery, and surrogacy. In-vitro fertilization (IVF) accounts for around 99% of all the ART treatments. Since IVF is one of the most popular assisted fertility techniques, its augmented adoption due to its enhanced rate of success will result in the strong growth of this market segment during the predicted period.
The IVF procedure
Source: Technavio, 2016
The leading vendors in the fertility market in the US include Cellcura, CooperSurgical, Intramed, Ferring Pharmaceuticals, and Merck. This market is highly fragmented due to the presence of many well-established vendors. The competitive scenario in this market is propelled by M&A and investments in R&D activities for the development of novel products. Since this market has low entry barriers, a number of players are expected to enter the market because of its high revenue generating potential. Furthermore, the consolidation of pharmaceutical companies will bolster the production of fertility drugs, which in turn will lead to market growth.
A more detailed analysis is available in the Technavio report, Fertility Market in the US 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
Further reading:
